|
|||||
|
 | |
| |
| |
| |
| |
| |
|
Gene: KIAA1430 |
Gene summary for KIAA1430 |
 Gene summary. |
| Gene information | Species | Human | Gene symbol | KIAA1430 | Gene ID | 57587 |
| Gene name | cilia and flagella associated protein 97 | |
| Gene Alias | KIAA1430 | |
| Cytomap | 4q35.1 | |
| Gene Type | protein-coding | GO ID | NA | UniProtAcc | Q9P2B7 |
Top |
Malignant transformation analysis |
| Identification of the aberrant gene expression in precancerous and cancerous lesions by comparing the gene expression of stem-like cells in diseased tissues with normal stem cells |
| Malignant transformation involving gene list. |
| Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
| 57587 | KIAA1430 | GSM5353215_PA_AUG_PB_1B_S2 | Human | Prostate | Tumor | 1.14e-06 | 6.33e-01 | 0.1557 |
| 57587 | KIAA1430 | GSM5353216_PA_PB1A_Pool_1_3_S50_L002 | Human | Prostate | Tumor | 2.22e-03 | 4.71e-01 | 0.159 |
| 57587 | KIAA1430 | GSM5353221_PA_PB2A_Pool_1_3_S25_L001 | Human | Prostate | Tumor | 6.16e-12 | 4.56e-01 | 0.1633 |
| 57587 | KIAA1430 | GSM5353222_PA_PB2B_Pool_1_3_S52_L002 | Human | Prostate | Tumor | 6.18e-13 | 4.33e-01 | 0.1608 |
| 57587 | KIAA1430 | GSM5353223_PA_PB2B_Pool_2_S26_L001 | Human | Prostate | Tumor | 1.19e-11 | 4.84e-01 | 0.1604 |
| 57587 | KIAA1430 | GSM5353224_PA_PR5186_Pool_1_2_3_S27_L001 | Human | Prostate | Tumor | 2.94e-10 | 3.93e-01 | 0.1621 |
| 57587 | KIAA1430 | GSM5353225_PA_PR5196-1_Pool_1_2_3_S53_L002 | Human | Prostate | Tumor | 3.41e-03 | 3.20e-01 | 0.1619 |
| 57587 | KIAA1430 | GSM5353226_PA_PR5196-2_Pool_1_2_3_S54_L002 | Human | Prostate | Tumor | 3.79e-09 | 6.61e-01 | 0.159 |
| 57587 | KIAA1430 | GSM5353227_PA_PR5199-193K_Pool_1_2_3_S55_L002 | Human | Prostate | Tumor | 5.40e-10 | 4.76e-01 | 0.1602 |
| 57587 | KIAA1430 | GSM5353236_PA_PR5251_T1_S7_L001 | Human | Prostate | Tumor | 5.29e-08 | 5.94e-01 | 0.1608 |
| 57587 | KIAA1430 | GSM5353240_PA_PR5254_T1_S15_L001 | Human | Prostate | Tumor | 1.62e-08 | 3.40e-01 | 0.1575 |
| 57587 | KIAA1430 | GSM5353243_PA_PR5261_T1_S23_L002 | Human | Prostate | Tumor | 1.49e-04 | 2.82e-01 | 0.1545 |
| 57587 | KIAA1430 | GSM5353244_PA_PR5261_T2_S24_L002 | Human | Prostate | Tumor | 4.28e-06 | 3.74e-01 | 0.1569 |
| 57587 | KIAA1430 | P1_cSCC | Human | Skin | cSCC | 2.52e-43 | 1.17e+00 | 0.0292 |
| 57587 | KIAA1430 | P2_cSCC | Human | Skin | cSCC | 1.14e-34 | 7.12e-01 | -0.024 |
| 57587 | KIAA1430 | P4_cSCC | Human | Skin | cSCC | 7.09e-57 | 8.81e-01 | -0.00290000000000005 |
| 57587 | KIAA1430 | P10_cSCC | Human | Skin | cSCC | 9.61e-45 | 9.60e-01 | 0.1017 |
| Page: 1 |
| Transcriptomic changes along malignancy continuum. |
| Tissue | Expression Dynamics | Abbreviation |
| Prostate |  | BPH: Benign Prostatic Hyperplasia |
| Skin |  | AK: Actinic keratosis |
| cSCC: Cutaneous squamous cell carcinoma | ||
| SCCIS:squamous cell carcinoma in situ |
| ∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
| Find out the enriched GO biological processes and KEGG pathways involved in transition from healthy to precancer to cancer |
| Figure of enriched GO biological processes. |
| Tissue | Disease Stage | Enriched GO biological Processes |
| Liver | Cyst |  |
| Lung | IAC |  |
| Lung | AIS |  |
| Lung | AAH |  |
| Lung | MIAC |  |
| ∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
| Page: 1 2 3 4 5 6 7 8 9 |
| Enriched GO biological processes. |
| GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
| Page: 1 |
| Enriched KEGG pathways. |
| Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
| Page: 1 |
Top |
Cell-cell communication analysis |
| Identification of potential cell-cell interactions between two cell types and their ligand-receptor pairs for different disease states |
| Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
| Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
| Find out the significant the regulons (TFs) and the target genes of each regulon across cell types for different disease states |
| TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
| ∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
| Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
| Annotation of somatic variants for genes involved in malignant transformation |
| Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
| Page: 1 |
Top |
Related drugs of malignant transformation related genes |
| Identification of chemicals and drugs interact with genes involved in malignant transfromation |
| (DGIdb 4.0) |
| Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
| Page: 1 |
Copyright 2023-Present -The University of Texas Health Science Center at Houston |